DnB Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-60,875
| Closed | -$1.73M | – | 753 |
|
|
2025
Q1 | $1.73M | Buy |
60,875
+3,120
| +5% | +$88.5K | 0.01% | 593 |
|
|
2024
Q4 | $2.4M | Buy |
57,755
+2,865
| +5% | +$119K | 0.01% | 549 |
|
|
2024
Q3 | $3.67M | Buy |
54,890
+1,930
| +4% | +$129K | 0.02% | 444 |
|
|
2024
Q2 | $6.29M | Buy |
52,960
+1,047
| +2% | +$124K | 0.03% | 311 |
|
|
2024
Q1 | $5.53M | Sell |
51,913
-10,288
| -17% | -$1.1M | 0.03% | 337 |
|
|
2023
Q4 | $6.19M | Sell |
62,201
-48,280
| -44% | -$4.8M | 0.03% | 320 |
|
|
2023
Q3 | $11.4M | Buy |
110,481
+43,337
| +65% | +$4.48M | 0.07% | 212 |
|
|
2023
Q2 | $8.16M | Buy |
67,144
+2,615
| +4% | +$318K | 0.05% | 272 |
|
|
2023
Q1 | $9.91M | Buy |
64,529
+2,941
| +5% | +$452K | 0.06% | 236 |
|
|
2022
Q4 | $11.1M | Buy |
61,588
+578
| +0.9% | +$104K | 0.08% | 207 |
|
|
2022
Q3 | $7.21M | Buy |
61,010
+458
| +0.8% | +$54.2K | 0.06% | 263 |
|
|
2022
Q2 | $8.65M | Buy |
60,552
+2,068
| +4% | +$295K | 0.06% | 238 |
|
|
2022
Q1 | $10.1M | Buy |
58,484
+4,861
| +9% | +$837K | 0.06% | 243 |
|
|
2021
Q4 | $13.6M | Buy |
53,623
+6,008
| +13% | +$1.53M | 0.08% | 195 |
|
|
2021
Q3 | $18.3M | Buy |
47,615
+4,959
| +12% | +$1.91M | 0.12% | 154 |
|
|
2021
Q2 | $10M | Buy |
42,656
+4,477
| +12% | +$1.05M | 0.07% | 223 |
|
|
2021
Q1 | $5M | Buy |
38,179
+165
| +0.4% | +$21.6K | 0.04% | 319 |
|
|
2020
Q4 | $3.97M | Buy |
38,014
+4,685
| +14% | +$489K | 0.03% | 315 |
|
|
2020
Q3 | $2.36M | Buy |
33,329
+2,332
| +8% | +$165K | 0.03% | 377 |
|
|
2020
Q2 | $1.99M | Buy |
+30,997
| New | +$1.99M | 0.02% | 388 |
|